Skip to main content

Table 4 Baseline and treatment-related predictors of total ASES score at week 104, based on univariate models

From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Variable Coefficient (95% CI) p-value Variable Coefficient p-value
Clinical/demographic    IPQ-R   
 Age 0.01 (0.00, 0.02) 0.056  Illness coherence 0.09 (0.06, 0.13) <0.001
 Gender (male) 0.36 (0.06, 0.66) 0.021  Treatment control 0.11 (0.05, 0.17) <0.001
 Ab-status (+) −0.03 (−0.37, 0.31) 0.856  Personal control 0.08 (0.04, 0.12) <0.001
 Erosive disease (+) 0.14 (−0.19, 0.46) 0.409  Emotional repr. −0.09 (−0.11, −0.07) <0.001
 RDCI −0.05 (−0.17, 0.07) 0.442  Consequences −0.09 (−0.13, −0.06) <0.001
 Treatment type 0.00 (−0.11, 0.10) 0.981 UCL   
 Treatment response −0.51 (−0.66, −0.36) <0.001  Seeking social support 0.04 (0.00, 0.08) 0.065
 HAQ −0.57 (−0.76, −0.37) <0.001  Passive reacting −0.11 (−0.15, −0.06) <0.001
 DAS28-CRP −0.07 (−0.18, 0.04) 0.222  Active tackling 0.05 (0.01, 0.09) 0.028
 PGA (VAS) −0.13 (−0.19, −0.07) <0.001  Palliative reacting −0.02 (−0.06, 0.02) 0.364
 TJC28 −0.01 (−0.03, 0.02) 0.543  Avoidance −.04 (−0.08, 0.01) 0.093
 SJC28 0.01 (−0.01, 0.04) 0.356  Expr. of emotion −0.03 (−0.11, 0.05) 0.484
 CRP 0.00 (−0.01, 0.00) 0.108  Reassuring thoughts 0.02 (−0.04, 0.08) 0.504
 ESR 0.00 (−0.01, 0.01) 0.782 SF-36   
 PhGA (VAS) −0.09 (−0.16, −0.02) 0.021  MCS 0.41 (0.29, 0.53) <0.001
 Pain (VAS) −0.12 (−0.18, −0.06) <0.001  VT 0.25 (0.19, 0.32) <0.001
 Fatigue (VAS) −0.14 (−0.20, −0.09) <0.001  SF 0.16 (0.11, 0.21) <0.001
RAQoL     MH 0.27 (0.20, 0.34) <0.001
 RAQoL −0.07 (−0.09, −0.05) <0.001  RE 0.09 (0.06, 0.12) <0.001
  1. Results were obtained from univariate linear regression models predicting the total ASES score at week 104. For this exploratory stage, no correction for multiple comparisons was applied
  2. ASES Arthritis Self-Efficacy Scale, RDCI Rheumatic Diseases Comorbidity Index, HAQ Health Assessment Questionnaire, DAS28-CRP Disease Activity Score in 28 joints with C-reactive protein, PGA patient’s global assessment of disease activity, TJC28 tender joint count in 28 joints, SJC28 swollen joint count in 28 joints, CRP C-reactive protein, ESR erythrocyte sedimentation rate, PhGA physician’s global assessment of disease activity, VAS visual analogue scale, SF-36 Short-Form 36, MCS mental component score, VT vitality, SF social function, MH mental health, RE Role Emotional, IPQ-R Revised Illness Perception Questionnaire, UCL Utrecht Coping List